Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PENG block versus sham placebo block for pain after elective hip arthroplasty
NL-OMON20932Not yet recruiting
- Start
- Jun 2021
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Randomised, triple-blind trial in postoperative pain comparing PENG block with ropivacaine with Sham placebo block (2 arms). Primary endpoint: Pain score on day of surgery. Planned start Jun 2021; status: not yet recruiting.
02
Drugs
ropivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NL-OMON20932.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON20932.